Evangelia Kalaitzoglou
ORCID: 0000-0002-0556-3975Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits”.
R. Clay Bunn, Sasidhar Uppuganti, Philip D. Ray, Iuliana Popescu, Evangelia Kalaitzoglou +3 more
R. Clay Bunn, Evangelia Kalaitzoglou, Phil Ray, Iuliana Popescu, Kathryn M. Thrailkill +1 more
Priya S. Srivastava, Thomas J. Hawke, Evangelia Kalaitzoglou, Callie Travis
Evangelia Kalaitzoglou, John L. Fowlkes, Kathryn M. Thrailkill
Edwina N. Barnett, Evangelia Kalaitzoglou, John L. Fowlkes, Ramkumar T. Annamalai, Harshini Suresh Kumar
Reuben Adatorwovor, Rebecca Smith, Philip D. Ray, Sarah E Fields, Alexander R. Keeble +6 more
Edwina N. Barnett, John L. Fowlkes, Evangelia Kalaitzoglou, Ramkumar T. Annamalai, Harshini Suresh Kumar